HJHaosen Ji

Haosen Ji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haosen Ji has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Dengming Lai

    Department of Neonatal Surgery, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China

    2 shared publications
  • Jinfa Tou

    Department of Neonatal Surgery, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China

    2 shared publications
  • Chengjie Lv

    Department of Neonatal Surgery, National Clinical Research Center for Child Health, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China

    1 shared publication
  • Chengjie Lyu

    Department of Neonatal Surgery, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China

    1 shared publication
  • Evropi Theodoratou

    Cancer Research UK Edinburgh Centre, Medical Research Council Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK

    1 shared publication
  • Jack Satsangi

    Nuffield Department of Medicine, University of Oxford, Oxford, UK

    1 shared publication

Latest Publications

  • Psychological Resilience and Mental Wellbeing Mitigate the Risk of Irritable Bowel Syndrome

    by Meng Zhang, Judith Wellens, Jianhui Zhao, Haosen Ji, Jing Sun, Xinxuan Li, Rahul Kalla, Yuan Ding, Evropi Theodoratou, Jack Satsangi, et al.

    INTRODUCTION: Comorbidities between mental disorders and irritable bowel syndrome (IBS) have been widely reported, yet associations between mental wellbeing and IBS, particularly regarding underlying genetic modification and proteomic signatures, remain underexplored. METHODS: This prospective cohort study analyzed 75,842 IBS-free participants aiming to investigate the prospective association between mental wellbeing and the risk of IBS in UK Biobank. Mental wellbeing was assessed through life satisfaction, positive affect, neuroticism, and depressive/anxiety symptoms. Cox models evaluate the hazard ratio (HR) for mental wellbeing and plasma proteome in relation to incident IBS during follow-up. Proteomic profiling identified mental wellbeing-associated proteins, with pathway enrichment analysis revealing biological mechanisms. Mediation and Mendelian randomization analyses further examine intermediate pathways and causality. RESULTS: With a 12.4-year follow-up period, 1,400 cases of incident IBS were documented. Better mental wellbeing mitigated IBS risk dose-dependently (low risk group: HR, 0.37; 95% confidence interval [CI]: 0.31–0.43). Higher life satisfaction (HR, 0.41; 95% CI: 0.30–0.56) and positive affect (HR, 0.50; 95% CI: 0.41–0.62) were inversely associated with IBS risk, whereas neuroticism (HR, 2.35; 95% CI: 1.92–2.88) and depressive/anxiety symptoms (HR, 3.09; 95% CI: 2.17–4.42) increased the risk. Findings remained consistent in across prevalent IBS and IBS subtypes. Mental wellbeing effects were independent of genetic predisposition. Mediation analyses revealed about 27% of protective effect of mental wellbeing were mediated through reduced depression and anxiety. Mendelian randomization supports causal protective effects of positive mental wellbeing on IBS. Proteomic profiling identified mental wellbeing-associated proteins mainly enriched in cytokine-cytokine receptor interactions. Chromogranin A and gastrin emerged as key protein biomarkers, showing significant associations with both mental wellbeing components and IBS risk. DISCUSSION: Our study demonstrates that enhanced mental wellbeing confers substantial protection against IBS development, highlighting psychological interventions as potential primary prevention strategies.


  • Open Access

    Mesenchymal Stem Cell Derived Exosomes Alleviates Hirschsprung‐Associated Enterocolitis by Inhibiting AKT Phosphorylation in Macrophages Through miR‐223

    by Haosen Ji, Zheming Xu, Leiting Shen, Sisi Yang, Jingyi Jin, Chengjie Lyu, Yichao Ren, Yi Xiao, Yuebai Zhang, Shu Fang, et al.

    Background: Mesenchymal stem cells (MSCs) inhibit macrophage inflammatory response and alleviate intestinal inflammation. However, the role of MSCs in Hirschsprung‐associated enterocolitis (HAEC) remains uncertain. This study aims to investigate the effects of MSCs on HAEC and the mechanisms related to macrophages and MSCs. Methods: Immunofluorescence was used to measure CD68 and p‐AKT in colonic tissues of HSCR patients with HAEC. Ednrb −/− mice was used as HSCR model. The proportion of colonic tissue macrophages in WT and Ednrb −/− mice was assessed by flow cytometry. The colonic tissues injury was evaluated with HE staining and the survival curves of mice were recorded. In vitro, macrophage‐induced enterocyte death was induced by lipopolysaccharide (LPS). MSCs, MSC derived exosomes, miR‐223, or MK2206 were added to macrophages, and the levels of miR‐223 in macrophages after exosome treatment were measured by RT‐qPCR. Flow cytometry was used to assess enterocyte death, western blot was performed to measure p‐AKT expression in macrophages, and enzyme‐linked immunosorbent assay (ELISA) was used to detect IL‐1β concentration in macrophage supernatants and serum of Edrnb −/− mice. Results: Increased expression of CD68 and p‐AKT was observed in the colonic tissues of HAEC patients. Colonic instillation of MSCs derived exosomes significantly reduce the inflammatory score of colonic tissues and prolong the survival time of HAEC mice. In vitro, LPS‐stimulated macrophages induce the phosphorylation of AKT and enterocyte death. Stimulation of macrophages with MSC‐derived exosomes increased the content of miR‐223. MSC‐derived exosomes, miR‐223 and MK2206 significantly reduce macrophage‐induced enterocyte death, attenuated AKT phosphorylation in macrophages, and decreased IL‐1β concentration in macrophage supernatants. Conclusion: Macrophages accumulate in colonic tissues during HAEC and inflammatory macrophages drive enterocyte death. MSCs derived exosomes reduce enterocyte death by suppressing AKT phosphorylation and IL‐1β secretion via miR‐223, and subsequently mitigate HAEC in mice. These findings suggest that MSC‐derived exosomes, particularly those enriched in miR‐223, may serve as a promising therapeutic strategy for the prevention or treatment of HAEC.


  • Open Access

    Macrophage α7nAChR alleviates the inflammation of neonatal necrotizing enterocolitis through mTOR/NLRP3/IL-1β pathway

    by Leiting Shen, Xiaohui Zhong, Haosen Ji, Sisi Yang, Jingyi Jin, Chengjie Lyu, Yichao Ren, Yi Xiao, Yuebai Zhang, Shu Fang, et al.